🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We validate the "FCS Score" in a large cohort of ethnically and genotypically diverse population from UK. HEART UK CardiovascularMFT ManchesterCVResearch The University of Manchester EAS Congress pubmed.ncbi.nlm.nih.gov/38447437/

Cardiovascular and Lipid research team at #hukconf #lipids HEART UK CardiovascularMFT MFT Research and Innovation

Into our oral abstract sessions starting with Dr Bilal Bashir (Manchester UK) in Medical & Scientific on Genetic Landscape of Familial Chlomicronaemia Syndrome (FCS) and Multifactorial Chlomicronaemia Syndrome (MCS) in United Kingdom. #hukconf #lipids

Dr Bilal Bashir, (Manchester UK) now presenting in the Primary & Healthcare oral abstracts Hypertriglyceridaemia & Cardiovascular Autonomic Function in Patients without Diabetes Mellitus #hukconf #lipids

And concluding the Primary & Healthcare Oral Abstracts is Dr Raabya Pasha, (Manchester UK) presenting Clinical service quality and unmet needs in Homozygous Familial Hypercholesterolaemia Patients: Insights from UK tertiary centres. #hukconf #lipids

Our team have been busy presenting at HEART UK conference this week #lipids #heartuk #neuropathy #diabetes #triglycerides

The first talk was by Bilal Bashir who presented his talk 'Genetic Landscape of Familial Chylomicronaemia Syndrome (FCS) and Multifactorial Chylomicronaemia Syndrome (MCS) in the UK

The 2nd talk by Bilal Bashir was on 'Hypertriglyceridaemia and Cardiovascular Autonomic Function in Patients Without Diabete Mellitus'

FCS leads to small fibre nerve damage, clinical neuropathy & early CAN Neurodiab HEART UK CardiovascularMFT National Organization for Rare Disorders (NORD) Rare Diseases

Hypertriglyceridaemia in absence of diabetes causes peripheral & cardiac autonomic neuropathy. Neurodiab HEART UK The University of Manchester CardiovascularMFT MFT Research and Innovation

Our latest article from UK FCS National Registry has been chosen as one of the two “Featured” articles in the November 2024 issue of ATVB: An AHA Journal ahajournals.org/doi/10.1161/AT…

In the occasion of the 150th Publication News NEUROdiab thanks the Members of the Discovery Team of Publication News (neurodiab.eu/discovery-team…)

Professor Soran with the Opening Remarks for the 14th Lipid and Atherosclerosis Forum: Utilising Recent Advances to Identify and Address Unmet Clinical Needs

Professor Dev Datta is presenting his work on 'New Therapies and Future of Lipoprotein Apheresis in the Management of HoFH' #Lipids #FH #HoFH

A wonderful and engaging first day of the 14th Lipid Forum. Superb speakers and presentations, we're a excited for Day 2, tomorrow! #EndoDiabLipid #Lipids #Diabetes #Education #Learning #Presentations #Forum endodiablipid.com

Professor Soran with the opening remarks for Day 2 of the Lipid Forum

A wonderful presentation by Maryam Ferdousi on 'Is Neuropathy Part of FCS Disease Burden?' #Neuropathy #Lipid #FCS #NeuroDiabLipid

CardiovascularMFT NW Greater Manchester Endodiab Trainees at Lipid Forum 10/12/2024

Which type of #MCS to choose? When to stop 🛑? How to manage #bleedingrisk 🩸and #thrombotic complications? This and much more at #ACVC2025!

Thrilled to finally share what has kept me occupied these past few months; our The Lancet Series on early-onset type 2 diabetes is out! Has been an honour to be the Lead Author for this Series brining together global experts; thanks Callam Davidson for inviting me People